Neuroprotective effect of mesenchymal stem cell-derived extracellular vesicles on optic nerve injury in chronic ocular hypertension

[INLINE:1] Mesenchymal stem cells have neuroprotective effects that limit damage to the retina and photoreceptors, and which may be mediated by extracellular vesicles (or exosomes) released by mesenchymal stem cells. To investigate the neuroprotective effect of extracellular vesicles derived from umbilical cord mesenchymal stem cells on glaucoma, we established rat models of chronic ocular hypertension by injecting conjunctival fibroblasts into the anterior chamber to mimic optic nerve injury caused by glaucoma. One week after injury, extracellular vesicles derived from umbilical cord-derived mesenchymal stem cells were injected into the vitreous cavity. We found that extracellular vesicles derived from mesenchymal stem cells substantially reduced retinal damage, increased the number of retinal ganglion cells, and inhibited the activation of caspase-3. These findings suggest that mesenchymal stem cell-derived extracellular vesicles can help alleviate optic nerve injury caused by chronic ocular hypertension, and this effect is achieved by inhibiting cell apoptosis.

[1]  Hao Sun,et al.  Astrocyte polarization in glaucoma: a new opportunity , 2022, Neural regeneration research.

[2]  Otilia-Maria Dumitrescu,et al.  Adherence to Therapy in Glaucoma Treatment—A Review , 2022, Journal of personalized medicine.

[3]  Wutian Wu,et al.  Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma , 2021, Stem cells international.

[4]  Chengyi Liu,et al.  Protective effects of intravitreal administration of mesenchymal stem cell-derived exosomes in an experimental model of optic nerve injury. , 2021, Experimental cell research.

[5]  A. Savardashtaki,et al.  Caspase‐3: Structure, function, and biotechnological aspects , 2021, Biotechnology and applied biochemistry.

[6]  B. Jaganathan,et al.  Stem Cell Therapy for Retinal Degeneration: The Evidence to Date , 2021, Biologics : targets & therapy.

[7]  Yuguo Xia,et al.  Embryonic Stem Cell Derived Small Extracellular Vesicles Modulate Regulatory T Cells to Protect against Ischemic Stroke. , 2021, ACS nano.

[8]  L. Mesentier-Louro,et al.  Human mesenchymal stem cell therapy promotes retinal ganglion cell survival and target reconnection after optic nerve crush in adult rats , 2021, Stem cell research & therapy.

[9]  G. Majdič,et al.  Comparison of Canine and Feline Adipose-Derived Mesenchymal Stem Cells/Medicinal Signaling Cells With Regard to Cell Surface Marker Expression, Viability, Proliferation, and Differentiation Potential , 2021, Frontiers in Veterinary Science.

[10]  J. Stein,et al.  Glaucoma in Adults-Screening, Diagnosis, and Management: A Review. , 2021, JAMA.

[11]  Sheng Wang,et al.  What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? , 2020, Stem cell research & therapy.

[12]  R. Lee,et al.  Cell transplantation to replace retinal ganglion cells faces challenges – the Switchboard Dilemma , 2020, Neural regeneration research.

[13]  Na Zhao,et al.  Photoreceptor protection by mesenchymal stem cell transplantation identifies exosomal MiR-21 as a therapeutic for retinal degeneration , 2020, Cell Death & Differentiation.

[14]  Xiangjun Li,et al.  Insights into stem cell therapy for diabetic retinopathy: a bibliometric and visual analysis , 2020, Neural regeneration research.

[15]  S. Mousavi,et al.  Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice. , 2020, Regenerative medicine.

[16]  H. Baharvand,et al.  Extracellular vesicles derived from human ES-MSCs protect retinal ganglion cells and preserve retinal function in a rodent model of optic nerve injury , 2020, Stem Cell Research & Therapy.

[17]  J. Pastor,et al.  Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration , 2020, Molecular therapy. Methods & clinical development.

[18]  T. Aung,et al.  Beyond intraocular pressure: Optimizing patient-reported outcomes in glaucoma , 2020, Progress in Retinal and Eye Research.

[19]  S. Tomarev,et al.  Extracellular vesicle therapy for retinal diseases , 2020, Progress in Retinal and Eye Research.

[20]  C. Habas,et al.  Glaucoma: A Degenerative Optic Neuropathy Related to Neuroinflammation? , 2020, Cells.

[21]  M. Yousefi,et al.  Human umbilical cord mesenchymal stem cell‐derived extracellular vesicles: A novel therapeutic paradigm , 2020, Journal of cellular physiology.

[22]  H. Nian,et al.  Human umbilical cord mesenchymal stem cells alleviate ongoing autoimmune dacryoadenitis in rabbits via polarizing macrophages into an anti-inflammatory phenotype. , 2019, Experimental eye research.

[23]  Q. Shu,et al.  Functional proteins of mesenchymal stem cell-derived extracellular vesicles , 2019, Stem Cell Research & Therapy.

[24]  Rajashekhar Gangaraju,et al.  Adult Stem Cell Therapeutics in Diabetic Retinopathy , 2019, International journal of molecular sciences.

[25]  K. Martin,et al.  Neuroprotection in Glaucoma: Towards Clinical Trials and Precision Medicine , 2019, Current eye research.

[26]  Qing Luo,et al.  Mesenchymal Stem Cell Migration and Tissue Repair , 2019, Cells.

[27]  D. Stolz,et al.  Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle‐Mediated Delivery of miRNA , 2019, Stem cells translational medicine.

[28]  Mei Chen,et al.  Immune regulation in the aging retina , 2019, Progress in Retinal and Eye Research.

[29]  Xiaorong Liu,et al.  Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. , 2019, Biomaterials.

[30]  Z. Ahmed,et al.  Mesenchymal Stem Cell–Derived Small Extracellular Vesicles Promote Neuroprotection in a Genetic DBA/2J Mouse Model of Glaucoma , 2018, Investigative ophthalmology & visual science.

[31]  Monica C. Chen,et al.  CD73, CD90, CD105 and Cadherin-11 RT-PCR Screening for Mesenchymal Stem Cells from Cryopreserved Human Cord Tissue , 2018, International journal of stem cells.

[32]  M. Soleimani,et al.  Fibrin gel as a scaffold for photoreceptor cells differentiation from conjunctiva mesenchymal stem cells in retina tissue engineering , 2018, Artificial cells, nanomedicine, and biotechnology.

[33]  Adnan Tufail,et al.  Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration , 2018, Nature Biotechnology.

[34]  M. Ghahremani,et al.  Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine , 2018, Stem Cell Research & Therapy.

[35]  C. Nucci,et al.  Neuroprotective agents in the management of glaucoma , 2018, Eye.

[36]  S. Tomarev,et al.  Mesenchymal Stem Cell–Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma , 2018, Investigative ophthalmology & visual science.

[37]  Hakho Lee,et al.  New Technologies for Analysis of Extracellular Vesicles. , 2018, Chemical reviews.

[38]  L. Levin,et al.  Neuroprotection in Glaucoma: Animal Models and Clinical Trials. , 2017, Annual review of vision science.

[39]  R. Zelkha,et al.  Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[40]  O. Julien,et al.  Caspases and their substrates , 2017, Cell Death and Differentiation.

[41]  Ajay E. Kuriyan,et al.  Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD. , 2017, The New England journal of medicine.

[42]  S. Tomarev,et al.  Bone Marrow‐Derived Mesenchymal Stem Cells‐Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA‐Dependent Mechanisms , 2017, Stem cells translational medicine.

[43]  Qiutang Li,et al.  Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1 , 2016, Scientific Reports.

[44]  J. Zhao,et al.  [Microcirculation of optic nerve head and glaucoma]. , 2016, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[45]  D. Zack,et al.  The Potential of Human Stem Cells for the Study and Treatment of Glaucoma , 2016, Investigative ophthalmology & visual science.

[46]  C. Théry,et al.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.

[47]  N. Puig,et al.  MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry , 2016, Cell Communication and Signaling.

[48]  A. Ljubimov,et al.  Progress in corneal wound healing , 2015, Progress in Retinal and Eye Research.

[49]  Renyi Wu,et al.  Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension , 2015, Molecular medicine reports.

[50]  Yun Xu,et al.  Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy , 2015, Expert opinion on biological therapy.

[51]  Fan Wang,et al.  Paracrine Action of Mesenchymal Stem Cells Revealed by Single Cell Gene Profiling in Infarcted Murine Hearts , 2015, PloS one.

[52]  Shinn-Zong Lin,et al.  Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy , 2015, Cell transplantation.

[53]  F. Medeiros,et al.  The pathophysiology and treatment of glaucoma: a review. , 2014, JAMA.

[54]  E. Stone,et al.  Allogenic iPSC-derived RPE cell transplants induce immune response in pigs: a pilot study , 2014, Scientific Reports.

[55]  N. Brecha,et al.  The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina , 2014, The Journal of comparative neurology.

[56]  M. Schwartz,et al.  The privileged immunity of immune privileged organs: the case of the eye , 2012, Front. Immun..

[57]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[58]  B. Morquette,et al.  The molecular basis of retinal ganglion cell death in glaucoma , 2012, Progress in Retinal and Eye Research.

[59]  Dorota L. Stankowska,et al.  Neuroprotection in Glaucoma , 2011 .

[60]  D. Zoukhri.  Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells. , 2010, The ocular surface.

[61]  J. Caprioli,et al.  RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. , 2010, Investigative ophthalmology & visual science.

[62]  K. Martin,et al.  Identification of barriers to retinal engraftment of transplanted stem cells. , 2010, Investigative ophthalmology & visual science.

[63]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[64]  J. Stein‐Streilein.  Immune regulation and the eye. , 2008, Trends in immunology.

[65]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[66]  R. Caspi.  Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells , 2008, Immunologic research.

[67]  A. Harvey,et al.  Caspase‐independent retinal ganglion cell death after target ablation in the neonatal rat , 2005, The European journal of neuroscience.

[68]  Xiangjun Yang,et al.  Caspase-independent component of retinal ganglion cell death, in vitro. , 2004, Investigative ophthalmology & visual science.

[69]  A. I. Valenciano,et al.  Generation of retinal ganglion cells is modulated by caspase‐dependent programmed cell death , 2003, The European journal of neuroscience.

[70]  D. Zack,et al.  Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. , 2002, Investigative ophthalmology & visual science.

[71]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[72]  Wendy W. Liu,et al.  Imaging Retinal Ganglion Cell Death and Dysfunction in Glaucoma. , 2019, International ophthalmology clinics.

[73]  David J. Wilson,et al.  Cell Transplantation for Retinal Degeneration: Transition from Rodent to Nonhuman Primate Models. , 2018, Advances in experimental medicine and biology.

[74]  A. Arsenijević,et al.  Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases. , 2018, Advances in experimental medicine and biology.

[75]  A. Regev,et al.  Extracellular Vesicle Isolation and Analysis by Western Blotting. , 2017, Methods in molecular biology.

[76]  R. Ritch,et al.  Glaucoma: Today and Tomorrow. , 2016, Asia-Pacific journal of ophthalmology.

[77]  B. Sabel,et al.  Caspase-3 inhibitor Z-DEVD-FMK enhances retinal ganglion cell survival and vision restoration after rabbit traumatic optic nerve injury. , 2015, Restorative neurology and neuroscience.

[78]  R. Kloner,et al.  Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. , 2007, Regenerative medicine.